CellFX Percutaneous Electrode

· Pulse Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CellFX Percutaneous Electrode, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules [NA]